Abstract| Volume 83, ISSUE 9, SUPPLEMENT , S245, May 01, 2018

F21. Standard Antidepressant Therapy in Posttraumatic Stress Disorder (PTSD) is Associated With a Higher Odds of Externalizing Behaviors and Homicidal Ideation: Results From the US Food and Drug Administration (FDA) Adverse Events Reporting System (FAERS)

      Irritable behavior and angry outburst (DSM-5 Criterion E.1) can be features of alteration in arousal and reactivity in PTSD. We examined post-marketing individual safety reports(ISR) of externalizing behaviors(EB) and homicidal ideation(HI) in PTSD patients where sertraline, paroxetine, fluoxetine, or venlafaxine (SER_PAR_FLU_VEN) (US Department of Defense recommended pharmacotherapies for PTSD) were reported as primary suspect (PS).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect